US tariffs on pharmaceuticals risk shortages of lower-cost generic drugs
- Oxfordshire MPs urged the Health Secretary to shield the county's pharmaceutical sector from potential tariffs.
- Reports suggest the Trump administration considers imposing tariffs on pharmaceutical imports.
- The MPs seek action to safeguard pharmaceutical companies and their services in Oxfordshire.
- Olly Glover voiced concern, stating possible pharmaceutical tariffs worry him particularly.
- The MPs want a task force to protect pharmaceutical companies both nationally and in Oxfordshire.
31 Articles
31 Articles
A Prescription for Risk: America’s Hidden Dependence on China for Life-Saving Drugs
China’s dominance of the market for "active pharmaceutical ingredients" — critical components of drugs — has given it powerful economic leverage and introduced significant risk into the American healthcare system. That must be considered in the imposition of tariffs on Chinese products.
Industry chief hopeful administration carves out generics from pharma tariffs
Tariffs that President Trump has repeatedly promised to levy on the pharmaceutical sector should exclude generic drugs, Association for Accessible Medicines President and CEO John Murphy tells Inside U.S. Trade, arguing that generic medicines are uniquely vulnerable to tariffs because of low profit margins and static government reimbursement rates. The Commerce Department last week opened a 21-day comment period for its investigation into the na…
Why Trump’s pharma tariffs are a political minefield
The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry and outside experts are raising red flags over worsening shortages and an extended fight over who will pay. The White House disclosed earlier this month it launched an investigation into whether pharmaceutical imports threaten national security, an effort to…
Coverage Details
Bias Distribution
- 53% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage